November 17, 2026 · Menopause (New York, N.Y.) · DOI: 10.1097/GME.0000000000002919

Breast cancer in premenopausal and postmenopausal women: clinicopathological findings and survival outcomes from a large registry-based cohort in Southern Iran.

Listen to this summary

This retrospective study of 6,930 women with breast cancer in the Shiraz Breast Cancer Registry (Iran, 2014–2022) asked how premenopausal and postmenopausal patients differ in tumor biology, treatment, and survival. Premenopausal women had more aggressive tumors (larger size, multifocality, necrosis, adverse pathology), while postmenopausal women had more estrogen receptor-positive tumors and received more hormone therapy. Five-year overall survival was similar between groups, and disease-free survival was modestly higher in postmenopausal women, but the authors conclude that menopausal status has limited independent prognostic value once age and tumor characteristics are accounted for.

Arshin Ghaedi, Masoumeh Ghoddusi Johari, Amirhossein Mallahi, Aida Bazrgar, Majid Akrami, Sedigheh Tahmasebi, Abdol-Rasoul Talei

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play